Learn more

CHARITE MED FAKULTAET

Overview
  • Total Patents
    37
About

CHARITE MED FAKULTAET has a total of 37 patent applications. Its first patent ever was published in 1986. It filed its patents most often in German Democratic Republic and Germany. Its main competitors in its focus markets biotechnology, medical technology and optics are KING FAISAL SPECIALIST HOSPITAL & RES CENTRE, UNIV SYDNEY TECH and PROVOST FELLOWS.

Patent filings in countries

World map showing CHARITE MED FAKULTAETs patent filings in countries
# Country Total Patents
#1 German Democratic Republic 26
#2 Germany 11

Patent filings per year

Chart showing CHARITE MED FAKULTAETs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Grunow Roland Dr Sc Med 5
#2 Von Baehr Ruediger 4
#3 Nugel Elsa 4
#4 Henklein Peter Dipl-Chem Dr Re 4
#5 Von Baehr Ruediger Prof Dr Sc 4
#6 Jahn Sigbert Dr Med 4
#7 Porstmann Tomas Prof Dr Sc Med 4
#8 Porstmann Baerbel Doz Dr Sc Me 3
#9 Liebetruth Jochen Dr Ing 3
#10 Ronneberger Heike 3

Latest patents

Publication Filing date Title
DE4222823A1 Device and method for the automatic characterization and control of the laser-tissue interaction
DE4209926A1 Handpiece for medical laser applications
DE4141970A1 Combination vaccine against AIDS, schistosomiasis and tuberculosis and process for its preparation
DE4132746A1 Cloning of cells producing a specific prod. - using a selective latex binding and staining technique
DE4130591A1 Fiber change handpiece for medical laser applications
DE4122906A1 Vaccines against viral or bacterial antigens and processes for their preparation
DE4122094A1 1,1,3,3,-Bis-polymethylene-2-(hetero)aryl-uronium salts - are condensn. agents with improved solubility properties, esp. for use in automated peptide syntheses
DE4115436A1 Fiber change - handpiece for medical laser applications
DE4109973A1 In ovo cultivation system for hybridoma cells
DE4101445A1 Determn. of ejaculate quality - by measuring concn. of microparticles
DE4033369A1 Selective factor VIII recovery from plasma - using chromatographic beds of biocompatible carriers for permeation chromatography contg. plant cell wall structures etc.
DD294970B5 Process for the preparation of recombinant p24 core proteins of HIV-1 from Escherichia coli
DD295985B5 Anti-tumor cell means
DD296102B5 Process for the preparation of natural human monoclonal antibodies having anti-tumor cell activity
DD296067B5 Process for the preparation of N (4-hydroxy-5-iodo-phenyl-ethylcarbonyloxy) -norborn-5-ene-2,3-dicarboximide
DD296083B5 Process for the preparation of iodinated peptides and polypeptides
DD293368B5 Process for producing monoclonal antibodies against the glycolysis enzyme Neuron-specific enolase
DD293134B5 Process for the preparation of monoclonal anti-D antibodies and a test preparation based thereon
DD291777B5 Process for the preparation of monoclonal antibodies against human erythrocytes
DD299090B5 Procedures and test kits for the follow-up of a complex therapy of HIV infection